No Data
No Data
ZimVie Jumps After Report on Buyout Talks With South Korea's Osstem
Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) P/E Still Appears To Be Reasonable
With a price-to-earnings (or "P/E") ratio of 23.7x Zimmer Biomet Holdings, Inc. (NYSE:ZBH) may be sending bearish signals at the moment, given that almost half of all companies in the United States
Truist Financial Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Announces Target Price $117
Truist Financial analyst Richard Newitter maintains $Zimmer Biomet Holdings(ZBH.US)$ with a hold rating, and sets the target price at $117.According to TipRanks data, the analyst has a success rate
Zimmer Biomet Holdings Is Maintained at Hold by Truist Securities
Zimmer Biomet Holdings Is Maintained at Hold by Truist
Morgan Stanley Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $120
Morgan Stanley analyst Drew Ranieri maintains $Zimmer Biomet Holdings(ZBH.US)$ with a hold rating, and maintains the target price at $120.According to TipRanks data, the analyst has a success rate
Express News | Zimmer Biomet Holdings Inc : Truist Securities Cuts Target Price to $117 From $130